CRISPR for Covid Testing and FDA EUAs

Published: May 17, 2020, 8:17 p.m.

with @jorgecondebio @andy23tran and @smc90\n\nBetter and widespread testing is key to re-opening the economy. So we discuss the first authorized use of CRISPR for testing -- diagnostics, not just therapeutics! -- and what the FDA's Emergency Use Authorization means. Where are we when it comes to CRISPR in practice?